We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+1.19%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$17.7B
AUM Growth
+$1.44B
(+8.9%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
8.95%
Top 10 Holdings %
Top 10 Hldgs %
19.92%
Holding
1,403
New
439
Increased
358
Reduced
346
Closed
241
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$403M |
| 2 |
Walt Disney
DIS
|
+$157M |
| 3 |
CELG
Celgene Corp
CELG
|
+$141M |
| 4 |
Citigroup
C
|
+$137M |
| 5 |
Starbucks
SBUX
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$244M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$178M |
| 3 |
Canadian National Railway
CNI
|
+$146M |
| 4 |
AT&T
T
|
+$139M |
| 5 |
Micron Technology
MU
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.79% |
| 3 | Healthcare | 17.78% |
| 4 | Consumer Staples | 7.98% |
| 5 | Consumer Discretionary | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
LyondellBasell Industries
LYB
$20B
| $131M | 0.74% |
1,262,901
+1,067,900
| +548% | +$107M |
|
27
Johnson & Johnson
JNJ
$618B
| $128M | 0.72% |
1,314,800
+1,270,300
| +2,855% | +$127M |
|
28
iShares MSCI Brazil ETF
EWZ
$9.28B
| $128M | 0.72% |
3,899,107
+3,763,507
| +2,775% | +$130M |
|
29
Lincoln National
LNC
$8.72B
| $127M | 0.72% |
2,148,953
-291,908
| -12% | -$17.1M |
|
30
Skyworks Solutions
SWKS
$9.37B
| $123M | 0.7% |
1,186,282
+17
| +0% | +$1.72K |
|
31
Biogen
BIIB
$30B
| $122M | 0.69% |
302,910
+300,810
| +14,324% | +$121M |
|
32
TJX Companies
TJX
$174B
| $116M | 0.66% |
3,511,802
+2,242,036
| +177% | +$74.6M |
|
|
CMCSK
33
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $115M | 0.65% |
1,910,358
+6,022
| +0.3% | +$361K |
|
34
Teva Pharmaceuticals
TEVA
$40.8B
| $114M | 0.64% |
+1,922,584
| New | +$119M |
|
35
F5
FFIV
$22.9B
| $112M | 0.64% |
933,515
+548,199
| +142% | +$67.4M |
|
36
ASML
ASML
$626B
| $110M | 0.62% |
1,056,526
-1,144,672
| -52% | -$122M |
|
37
SAP
SAP
$212B
| $109M | 0.62% |
1,558,732
+450,393
| +41% | +$33.4M |
|
|
TWC
38
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $108M | 0.61% |
607,201
-1,075,753
| -64% | -$178M |
|
39
Ulta Beauty
ULTA
$22B
| $108M | 0.61% |
699,409
+383,749
| +122% | +$59M |
|
40
Voya Financial
VOYA
$9.01B
| $106M | 0.6% |
2,287,548
-282,356
| -11% | -$12.7M |
|
41
Bristol-Myers Squibb
BMY
$133B
| $106M | 0.6% |
1,597,300
+1,426,500
| +835% | +$94M |
|
|
SHPG
42
DELISTED
Shire pic
SHPG
| $105M | 0.59% |
433,086
-161,963
| -27% | -$40.2M |
|
43
CVS Health
CVS
$133B
| $103M | 0.58% |
978,818
-711,189
| -42% | -$72.7M |
|
44
Cencora
COR
$60.6B
| $101M | 0.57% |
+951,015
| New | +$107M |
|
45
Elevance Health
ELV
$81.5B
| $96.9M | 0.55% |
590,210
+17,526
| +3% | +$2.8M |
|
|
CERN
46
DELISTED
Cerner Corp
CERN
| $96.3M | 0.54% |
1,393,967
+923,792
| +196% | +$64.7M |
|
47
Lockheed Martin
LMT
$134B
| $96.2M | 0.54% |
517,373
-8,532
| -2% | -$1.64M |
|
48
iShares MSCI South Korea ETF
EWY
$21.9B
| $95.6M | 0.54% |
1,733,972
+1,711,335
| +7,560% | +$100M |
|
49
AerCap
AER
$23.7B
| $93M | 0.53% |
2,030,291
+1,292,738
| +175% | +$61.3M |
|
50
Ameriprise Financial
AMP
$48.3B
| $90.9M | 0.51% |
727,237
+74,125
| +11% | +$9.45M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Arrowstreet Capital held 1,403 positions worth $17.7B, up 8.9% from $16.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Arrowstreet Capital deployed $1.58B of net new capital in Q2 2015, opening 439 new positions and adding to 358 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Union Pacific, an estimated $244M trimmed.
- Arrowstreet Capital's largest Q2 2015 buy was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
- Arrowstreet Capital added most to Apple in Q2 2015, an estimated $403M increase.
- Arrowstreet Capital's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $244M.
- Arrowstreet Capital fully exited Canadian National Railway in Q2 2015, selling an estimated $146M.
- Arrowstreet Capital's ten largest holdings make up 20% of its $17.7B portfolio in Q2 2015.
- Arrowstreet Capital opened 439 new positions and closed 241 in Q2 2015.
- Arrowstreet Capital's portfolio value rose 8.9% quarter-over-quarter to $17.7B.
Based on Arrowstreet Capital's 13F filing for Q2 2015, filed 13 Aug 2015.